Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 10:02 ET | Source: E.C.D. Automotive Design

ECD Automotive Design Continues ECD x Chelsea Truck Company Defenders Following Strategic Alliance

This factory-new Defender 110 V8 is one of many vehicles to roll out under the ECD x CTC collaboration, setting the tone for a new era.
January 09, 2026 09:29 ET | Source: Heron Therapeutics, Inc.

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited...
January 09, 2026 09:25 ET | Source: Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry

Ping An Biomedical (NASDAQ: PASW) will invest in Future Biotechnology Group to enhance AI-driven biopharma R&D and strengthen industry synergy.
January 09, 2026 09:15 ET | Source: Rubico Inc.

Rubico Announces Pricing of $4.0 Million Public Offering

ATHENS, Greece, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Rubico Inc. (“Rubico” or the “Company”) (Nasdaq: RUBI), a global provider of shipping transportation services specializing in the ownership of...
January 09, 2026 09:15 ET | Source: Oriental Rise Holdings Limited

Oriental Rise Holdings Limited Signs Non-Binding Letter of Intent to Acquire PoDu White Tea Beverage Brand and Related Assets

Proposed Transaction Expected to Expand Ready-to-Drink Product Portfolio, Enhance White Tea Value Chain, and Broaden Health-Oriented Consumption Scenarios NINGDE, China, Jan. 09, 2026 (GLOBE...
January 09, 2026 09:01 ET | Source: ENvue Medical, Inc.

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

TYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing on the...
January 09, 2026 09:00 ET | Source: RenX Enterprises Corp.

RenX Enterprises Corp. Highlights Transformational Year with Expected $7 Million in Revenues during 2025, Operating Scale, and Debt Reduction

MIAMI, FL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (the “Company”) today provided an update on a year that management views as transformational, reflecting a...
January 09, 2026 09:00 ET | Source: CLOUDASTRUCTURE, INC.

Cloudastructure Launches AI-Powered Security Enclosure

PALO ALTO, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a leader in AI-powered video surveillance and remote...
January 09, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today provided...
January 09, 2026 09:00 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for...